missing translation for 'onlineSavingsMsg'
Learn More

MGCD-265 analog, MedChemExpress

Product Code. 16497047
Encompass_Preferred
Change view
Click to view available options
Quantity:
2 mg
5 mg
10 mg
50 mg
Unit Size:
10mg
2mg
50mg
5mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16497047 5 mg 5mg
16480657 50 mg 50mg
16430136 2 mg 2mg
16424338 10 mg 10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
This item is not returnable. View return policy
Product Code. 16497047 Supplier Medchem Express Supplier No. HY10991

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress MGCD-265 analog is a potent and oral active inhibitor of c-Met and VEGFR2 tyrosine kinases, with IC50s of 29 nM and 10 nM, respectively. MGCD-265 analog has significant antitumor activity.

MGCD-265 analog is a potent and oral active inhibitor of c-Met and VEGFR2 tyrosine kinases, with IC50s of 29 nM and 10 nM, respectively. MGCD-265 analog has significant antitumor activity.

Specifications

Chemical Name or Material MGCD-265 analog
CAS 875337-44-3
Color White
Purity Grade Notes Research
Molecular Formula C26H20FN5O2S2
Quantity 5 mg
Solubility Information DMSO : ≥ 100 mg/mL (193.20 mM)
SMILES O=C(CC1=CC=CC=C1)NC(NC2=CC=C(C(F)=C2)OC3=C4C(C=C(S4)C5=CN(C=N5)C)=NC=C3)=S
Molecular Weight (g/mol) 517.6
Formula Weight 517.6
Percent Purity 98.57%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.